NASDAQ$ULBI

Ultralife Corporation · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Briefing

Ultralife Corporation reported its second quarter 2025 financial results with revenues of $48.6 million.

For the three months ended June 30, 2025, Ultralife achieved revenues of $48.6 million and net income attributable to the company of $0.9 million. Gross margin improved to 23.9% driven by product mix in both segments. The company continued investments in new product development while maintaining disciplined cost controls.

  • Revenues totaled $48.6 million, down 1.3% year-over-year due to lower commercial sales partially offset by higher government/defense sales.
  • Gross profit reached $11.6 million, representing a 23.9% gross margin, up 500 basis points from the prior year.
  • Operating income was $2.3 million, or 4.6% of revenues, supported by segment contribution improvements.
  • Net income attributable to Ultralife Corporation was $0.9 million, or $0.05 per diluted share.

Headline financials

Total Revenue

$48.6M

Previous: $43M+13.0%
EPS (adj)

$0.05

Previous: $0.21-76.2%
Gross Margin

23.9%

Previous: 26.9%-11.2%
Capital Expenditures

-$2M

Previous: -$732K-172.5%
Net Income

$879K

Previous: $2.97M-70.4%
Operating Income

$2.26M

Previous: $3.92M-42.4%
Gross Profit

$11.6M

Previous: $11.6M+0.3%

Revenue & EPS history

Ultralife · Revenue · Quarterly

$48.6M

Q2 2025+13%vs Q2 2024
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Revenue by segment

Ultralife · $48.6M total across 2 segments · Q2 2025

  • Battery & Energy Products
    $45.9M
  • Communications Systems
    $2.69M

Forward guidance

The company remains focused on converting new product development into revenue, improving gross margins through operational efficiency, and generating cash flow to reduce debt.

Tailwinds

  • Strong backlog exiting the quarter at $84.5 million
  • Continued investment in new products for government/defense and commercial markets

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+5.4%

Avg return

30 days after

46%

30 / 65 earnings

Positive

+56.6%

Q2 2023

Best reaction

-26.7%

Q2 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2026-14.3%-16.4%-4.6%
Q4 2025+8.3%+22.9%+28.5%
Q3 2025-9.0%-5.4%+4.7%
Q1 2025+2.9%+13.1%+57.8%
Q4 2024-6.1%-16.0%-18.2%
Q3 2024-14.3%-16.5%-18.3%
Q2 2024-3.1%-4.1%-1.8%
Q1 2024+30.5%+34.0%+29.4%
Q4 2023+16.5%+11.6%+6.6%
Q3 2023-22.3%-19.3%-18.2%
Q2 2023+56.6%+70.8%+87.4%
Q1 2023+3.6%-1.2%+4.9%
Q4 2022+0.5%-3.2%-0.2%
Q3 2022-4.6%-7.1%-15.4%
Q2 2022-4.1%-1.9%+8.8%
Q1 2022+6.4%+3.9%+7.1%
Q4 2021-7.4%-9.1%+0.9%
Q3 2021-9.3%-7.4%-19.9%
Q2 2021-6.3%-4.8%-5.3%
Q1 2021-1.4%-3.5%+14.0%
Q4 2020+8.2%+24.6%+11.9%
Q3 2020-9.8%-6.5%+20.1%
Q2 2020+1.7%+1.0%-9.7%
Q1 2020+7.6%+19.7%+19.3%
Q4 2019+11.4%+12.7%+0.0%
Q3 2019-7.1%-5.5%-6.4%
Q2 2019+6.0%-1.8%-1.8%
Q1 2019-18.1%-23.2%-30.0%
Q4 2018+4.1%+12.9%+26.1%
Q3 2018+10.9%+9.7%+8.4%
Q2 2018-3.5%-1.0%-13.5%
Q1 2018+3.3%+0.0%+12.1%
Q4 2017+7.6%+8.3%+19.7%
Q3 2017-14.3%-12.2%-12.9%
Q2 2017-2.2%-4.3%-6.5%
Q1 2017+7.2%+6.3%+20.7%
Q4 2016-1.0%+6.9%+8.8%
Q3 2016-7.8%-8.9%+6.7%
Q2 2016-7.6%-13.8%-11.0%
Q1 2016-11.0%
Q4 2015-4.5%
Q3 2015+5.3%
Q2 2015+0.0%
Q1 2015+1.5%
Q4 2014+9.7%
Q3 2014+5.7%
Q2 2014-8.3%
Q1 2014+7.2%
Q4 2013-5.2%
Q3 2013-4.5%
Q2 2013-0.3%
Q1 2013+1.8%
Q4 2012+11.2%
Q3 2012+5.9%
Q2 2012-26.7%
Q1 2011+0.5%
Q1 2012-1.0%
Q4 2011+0.6%
Q4 2009+0.6%
Q3 2011-3.0%
Q3 2010-3.0%
Q4 2010-0.2%
Q2 2010-0.2%
Q2 2011-0.2%
Q1 2010+4.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro